David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
China Yuchai International
CYD
$1.45B
| $129K | ﹤0.01% |
13,049
-41,375
| -76% | -$401K |
|
3227
Rockwell Medical
RMTI
$31.8M
| $128K | ﹤0.01% |
+156
| New | +$123K |
|
3228
Titan Machinery
TITN
$444M
| $128K | ﹤0.01% |
+11,089
| New | +$109K |
|
|
UNXL
3229
DELISTED
Uni-Pixel, Inc.
UNXL
| $128K | ﹤0.01% |
138,577
+5,472
| +4% | +$3.1K |
|
|
VIRX
3230
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $126K | ﹤0.01% |
1,119
-7
| -0.6% | -$1.06K |
|
|
ICON
3231
DELISTED
Iconix Brand Group, Inc.
ICON
| $126K | ﹤0.01% |
1,560
-3,288
| -68% | -$238K |
|
3232
Assembly Biosciences
ASMB
$718M
| $125K | ﹤0.01% |
2,077
+835
| +67% | +$55.8K |
|
|
BCIC
3233
BCP Investment Corp
BCIC
$94.9M
| $125K | ﹤0.01% |
+3,467
| New | +$110K |
|
|
NAV
3234
CALL
DELISTED
Navistar International
NAV
| $125K | ﹤0.01% |
10,000
-50,000
| -83% | -$456K |
|
|
TESO
3235
DELISTED
Tesco Corp
TESO
| $124K | ﹤0.01% |
14,443
+4,338
| +43% | +$30.6K |
|
|
DMTX
3236
DELISTED
Dimension Therapeutics, Inc
DMTX
| $124K | ﹤0.01% |
15,850
-3,958
| -20% | -$31.2K |
|
3237
Ardmore Shipping
ASC
$746M
| $120K | ﹤0.01% |
14,165
-115,604
| -89% | -$1.03M |
|
3238
Independence Realty Trust
IRT
$3.98B
| $120K | ﹤0.01% |
+16,919
| New | +$114K |
|
3239
Enphase Energy
ENPH
$4.91B
| $119K | ﹤0.01% |
51,010
-6,465
| -11% | -$15.9K |
|
|
GPT
3240
DELISTED
Gramercy Property Trust
GPT
| $119K | ﹤0.01% |
4,710
-49,050
| -91% | -$1.1M |
|
3241
Sunrun
RUN
$2.15B
| $118K | ﹤0.01% |
18,259
+2,798
| +18% | +$20.1K |
|
|
MN
3242
DELISTED
MANNING & NAPIER, INC.
MN
| $118K | ﹤0.01% |
+14,658
| New | +$108K |
|
3243
Tilly's
TLYS
$114M
| $116K | ﹤0.01% |
17,327
-6,388
| -27% | -$43.9K |
|
3244
Oaktree Specialty Lending
OCSL
$1.16B
| $114K | ﹤0.01% |
7,595
-2,619
| -26% | -$41K |
|
3245
PDS Biotechnology
PDSB
$12.1M
| $112K | ﹤0.01% |
613
-1,100
| -64% | -$197K |
|
3246
Madrigal Pharmaceuticals
MDGL
$11.8B
| $110K | ﹤0.01% |
13,045
-9,934
| -43% | -$83K |
|
|
PSV
3247
DELISTED
Hermitage Offshore Services Ltd.
PSV
| $110K | ﹤0.01% |
2,447
-2,695
| -52% | -$118K |
|
3248
Compugen
CGEN
$245M
| $108K | ﹤0.01% |
19,401
+8,761
| +82% | +$45.8K |
|
3249
Harmony Gold Mining
HMY
$14.3B
| $108K | ﹤0.01% |
29,702
-1,274,262
| -98% | -$3.34M |
|
|
PDS
3250
Precision Drilling
PDS
$1.13B
| $108K | ﹤0.01% |
1,295
+570
| +79% | +$40.7K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.